Journal of the American Academy of Dermatology · 2025
Understanding factors impacting quality of life in patients with keratinocyte carcinoma: A cross-sectional analysis of Mohs surgery patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fagan Evelyn, McGrath Joseph, Shostrom Valerie K, Voss Vanessa, Sutton Adam
Аннотация
BACKGROUND: Keratinocyte carcinomas are the most common malignancy in the U.S. and may substantially affect quality of life (QoL). Few studies have assessed both general and skin cancer-specific QoL or examined how patient-level factors contribute to these outcomes.
OBJECTIVE: To assess general and skin cancer-specific QoL in individuals with keratinocyte carcinomas and identify demographic and clinical predictors of QoL impairment.
METHODS: This cross-sectional study included 1138 patients undergoing treatment for keratinocyte carcinomas at a single academic center. Participants completed surveys assessing demographics, disease history, health care utilization, and QoL using the Skin Cancer Index, short form-20, and a care burden score. Field cancerization classification categorized cumulative skin cancer history.
RESULTS: Younger age, female sex, family history of skin cancer, higher field cancerization class, frequent dermatology visits, and chemoprevention use were significantly associated with poorer Skin Cancer Index and short form-20 scores. QoL appeared most impacted in the emotional and appearance domains of the Skin Cancer Index and the health perception domain of the short form-20.
LIMITATIONS: Single-center design, cross-sectional data, and self-reported measures.
CONCLUSION: Identifying risk groups and the specific quality of life domains they value most may help clinicians deliver more personalized education and support strategies to improve patient-centered care.
OBJECTIVE: To assess general and skin cancer-specific QoL in individuals with keratinocyte carcinomas and identify demographic and clinical predictors of QoL impairment.
METHODS: This cross-sectional study included 1138 patients undergoing treatment for keratinocyte carcinomas at a single academic center. Participants completed surveys assessing demographics, disease history, health care utilization, and QoL using the Skin Cancer Index, short form-20, and a care burden score. Field cancerization classification categorized cumulative skin cancer history.
RESULTS: Younger age, female sex, family history of skin cancer, higher field cancerization class, frequent dermatology visits, and chemoprevention use were significantly associated with poorer Skin Cancer Index and short form-20 scores. QoL appeared most impacted in the emotional and appearance domains of the Skin Cancer Index and the health perception domain of the short form-20.
LIMITATIONS: Single-center design, cross-sectional data, and self-reported measures.
CONCLUSION: Identifying risk groups and the specific quality of life domains they value most may help clinicians deliver more personalized education and support strategies to improve patient-centered care.